Immediate Impact
2 by Nobel laureates 1 from Science/Nature 55 standout
Citing Papers
BRAF — a tumour-agnostic drug target with lineage-specific dependencies
2024 Standout
Immune checkpoint therapy—current perspectives and future directions
2023 StandoutNobel
Works of Guo Yu being referenced
Cobimetinib plus atezolizumab in BRAFV600 wild-type melanoma: primary results from the randomized phase III IMspire170 study
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Guo Yu | 565 | 69 | 156 | 211 | 201 | 96 | 1.4k | |
| Maria Chaudhry | 523 | 86 | 112 | 136 | 112 | 38 | 1.6k | |
| Shoko Kobayashi | 509 | 66 | 73 | 206 | 179 | 56 | 1.6k | |
| Yue Shi | 704 | 107 | 45 | 150 | 97 | 73 | 1.5k | |
| Gérard Lescoat | 503 | 160 | 416 | 91 | 343 | 75 | 1.9k | |
| Shagufta Moin | 451 | 80 | 102 | 92 | 74 | 47 | 1.6k | |
| Neda Roshanravan | 786 | 205 | 46 | 146 | 209 | 86 | 1.8k | |
| Jean‐Francois Marier | 524 | 200 | 70 | 87 | 118 | 68 | 2.0k | |
| A. Süha Yalçın | 452 | 89 | 113 | 110 | 158 | 55 | 1.5k | |
| Mohd Nazam Ansari | 673 | 74 | 37 | 172 | 152 | 132 | 2.1k | |
| Marcelo Alarcón | 539 | 147 | 111 | 128 | 141 | 67 | 1.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...